Incorporation of transition to transversion ratio and nonsense mutations, improves the estimation of the number of synonymous and non-synonymous sites in codons
DNA Research · 25.06.2022 · 29 (4)
DOI: 10.1093/dnares/dsac023 ↗Kurz gefasst
Fachartikel in der Zeitschrift DNA Research, online erschienen am 03.08.2022. Verfasst von Ruksana Aziz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028 Assam, India. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Selection, Genetic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A common approach to estimate the strength and direction of selection acting on protein coding sequences is to calculate the dN/dS ratio. The method to calculate dN/dS has been widely used by many researchers and many critical reviews have been made on its application after the proposition by Nei and Gojobori in 1986. However, the method is still evolving considering the non-uniform substitution rates and pretermination codons. In our study of SNPs in 586 genes across 156 Escherichia coli strains, synonymous polymorphism in 2-fold degenerate codons were higher in comparison to that in 4-fold degenerate codons, which could be attributed to the difference between transition (Ti) and transversion (Tv) substitution rates where the average rate of a transition is four times more than that of a transversion in general. We considered both the Ti/Tv ratio, and nonsense mutation in pretermination codons, to improve estimates of synonymous (S) and non-synonymous (NS) sites. The accuracy of estimating dN/dS has been improved by considering the Ti/Tv ratio and nonsense substitutions in pretermination codons. We showed that applying the modified approach based on Ti/Tv ratio and pretermination codons results in higher values of dN/dS in 29 common genes of equal reading-frames between E. coli and Salmonella enterica. This study emphasizes the robustness of amino acid composition with varying codon degeneracy, as well as the pretermination codons when calculating dN/dS values.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028 Assam, India.
- Department of Computer Science and Engineering, Tezpur University, Tezpur, 784028 Assam, India.
- TCS Innovation, Tata Consultancy Services, Hyderabad, 500081 Telangana, India.
- Department of Electronics and Communication Engineering, NIT, Papum Pare, 791113 Arunachal Pradesh, India.
- Center for Multidisciplinary Research, Tezpur University, Tezpur, 784028 Assam, India.
- Department of Chemical Sciences, Tezpur University, Tezpur, 784028 Assam, India.
Zitieren
APA
Aziz, R., Sen, P., Beura, P. K., Das, S., Tula, D., Dash, M., Namsa, N. D., Deka, R. C., Feil, E. J., Satapathy, S. S., & Ray, S. K. (2022). Incorporation of transition to transversion ratio and nonsense mutations, improves the estimation of the number of synonymous and non-synonymous sites in codons. DNA Research, 29(4). https://doi.org/10.1093/dnares/dsac023
Vancouver
Aziz R, Sen P, Beura PK, Das S, Tula D, Dash M, et al. Incorporation of transition to transversion ratio and nonsense mutations, improves the estimation of the number of synonymous and non-synonymous sites in codons. DNA Research. 2022;29(4). doi:10.1093/dnares/dsac023
BibTeX
@article{Aziz2022,
author = {Aziz, Ruksana and Sen, Piyali and Beura, Pratyush Kumar and Das, Saurav and Tula, Debapriya and Dash, Madhusmita and Namsa, Nima Dondu and Deka, Ramesh Chandra and Feil, Edward J and Satapathy, Siddhartha Sankar and Ray, Suvendra Kumar},
title = {Incorporation of transition to transversion ratio and nonsense mutations, improves the estimation of the number of synonymous and non-synonymous sites in codons},
journal = {DNA Research},
year = {2022},
volume = {29},
number = {4},
doi = {10.1093/dnares/dsac023}
}
EUVIMED